Oxytetracycline hydrochloride CAS:2058-46-0

In human medicine, oxytetracycline hydrochloride is indicated for the treatment of respiratory tract infections such as pneumonia and bronchitis, as well as skin and soft tissue infections including acne, rosacea, and infected wounds. Its broad spectrum of activity allows for efficacy against common pathogens like Staphylococcus aureus, Streptococcus pneumoniae, and Mycoplasma pneumoniae. In veterinary medicine, oxytetracycline hydrochloride finds widespread use in the management of bacterial infections in livestock and poultry. It is administered orally, intramuscularly, or intravenously to treat and prevent respiratory infections, enteritis, mastitis, and other bacterial diseases affecting farm animals. Oxytetracycline hydrochloride plays a vital role in maintaining animal health and productivity in agriculture. Topical formulations of oxytetracycline hydrochloride are also available for veterinary use in the treatment of localized infections, including wounds, abscesses, and dermatological conditions such as foot rot in cattle and sheep. These formulations offer targeted antimicrobial therapy while minimizing systemic exposure and potential adverse effects. Adverse effects associated with oxytetracycline hydrochloride therapy are similar to those of other tetracyclines and may include gastrointestinal disturbances, photosensitivity reactions, and rare but serious complications such as hepatotoxicity and renal dysfunction. Proper medication administration, monitoring for adverse effects, and completion of the full treatment course are essential for optimal outcomes and to minimize the risk of antibiotic resistance. Collaboration between healthcare professionals and veterinarians is essential for the responsible use of oxytetracycline hydrochloride in both human and veterinary medicine, ensuring effective treatment while safeguarding public health.